journal article·2023-05-17Open access

CuFeS2 Nanoparticles Functionalized with a Thermoresponsive Polymer for Photothermia and Externally Controlled Drug Delivery

John S. Conteh, Giulia E. P. Nucci, Tamara Fernandez Cabada, Binh T. Mai, Nisarg Soni, Francesco De Donato, Lea Pasquale, Federico Catalano, Mirko Prato, Liberato Manna, Teresa Pellegrino

ACS Applied Materials & Interfaces· Volume 15· Issue 19

Abstract

High Resolution Image Download MS PowerPoint Slide CuFeS 2 chalcopyrite nanoparticles (NPs) can generate heat under exposure to near-infrared laser irradiation. Here, we develop a protocol to decorate the surface of CuFeS 2 NPs (13 nm) with a thermoresponsive (TR) polymer based on poly(ethylene glycol methacrylate) to combine heat-mediated drug delivery and photothermal heat damage. The resulting TR-CuFeS 2 NPs feature a small hydrodynamic size (∼75 nm), along with high colloidal stability and a TR transition temperature of 41 °C in physiological conditions. Remarkably, TR-CuFeS 2 NPs, when exposed to a laser beam (in the range of 0.5 and 1.5 W/cm 2 ) at NP concentrations as low as 40–50 μg Cu/mL, exhibit a high heating performance with a rise in the solution temperature to hyperthermia therapeutic values (42–45 °C). Furthermore, TR-CuFeS 2 NPs worked as nanocarriers, being able to load an appreciable amount of doxorubicin (90 μg DOXO/mg Cu), a chemotherapeutic agent whose release could then be triggered by exposing the NPs to a laser beam (through which a hyperthermia temperature above 42 °C could be reached). In an in vitro study performed on U87 human glioblastoma cells, bare TR-CuFeS 2 NPs were proven to be nontoxic at a Cu concentration up to 40 μg/mL, while at the same low dose, the drug-loaded TR-CuFeS 2 -DOXO NPs displayed synergistic cytotoxic effects due to the combination of direct heat damage and DOXO chemotherapy, under photo-irradiation by a 808 nm laser (1.2 W/cm 2 ). Finally, under a 808 nm laser, the TR-CuFeS 2 NPs generated a tunable amount of reactive oxygen species depending on the applied power density and NP concentration.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Quantum Dots Synthesis And Properties · Nanoplatforms for cancer theranostics · Chalcogenide Semiconductor Thin Films

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Italian Institute of Technology, via Morego 30, 16163 Genoa, Italy

Dipartimento di Chimica e Chimica Industriale, Università di Genova, Via Dodecaneso 31, 16146 Genoa, Italy

Funding

H2020 European Research Council · Associazione Italiana per la Ricerca sul Cancro

References (75)

Show source-provided references
1. 10.1080/21691401.2018.143655310.1080/21691401.2018.1436553 ↗
2. 10.3892/mmr.2019.1021810.3892/mmr.2019.10218 ↗
3. 10.1039/d0bm00222d10.1039/d0bm00222d ↗
4. 10.1039/c8nr07627h10.1039/c8nr07627h ↗
5. 10.1021/acsami.6b1680110.1021/acsami.6b16801 ↗
6. 10.1039/c5cc08317f10.1039/c5cc08317f ↗
7. 10.1021/acsami.9b0686610.1021/acsami.9b06866 ↗
8. 10.1021/acsami.6b1670510.1021/acsami.6b16705 ↗
9. 10.1021/nn506687t10.1021/nn506687t ↗
10. 10.1039/CS995240001910.1039/CS9952400019 ↗
11. 10.1007/s12551-019-00532-310.1007/s12551-019-00532-3 ↗
12. 10.1039/d1nr00323b10.1039/d1nr00323b ↗
13. 10.7150/thno.1073110.7150/thno.10731 ↗
14. 10.1002/adfm.20120166310.1002/adfm.201201663 ↗
15. 10.1016/j.jconrel.2011.10.02810.1016/j.jconrel.2011.10.028 ↗
16. 10.1016/j.ijpharm.2018.01.03410.1016/j.ijpharm.2018.01.034 ↗
17. 10.1016/j.jare.2010.02.00210.1016/j.jare.2010.02.002 ↗
18. 10.1002/adom.20170000410.1002/adom.201700004 ↗
19. 10.1016/j.ccr.2019.02.02510.1016/j.ccr.2019.02.025 ↗
20. 10.1007/s12551-019-00532-310.1007/s12551-019-00532-3 ↗
21. 10.1016/j.jcis.2018.08.06910.1016/j.jcis.2018.08.069 ↗
22. 10.3389/fchem.2019.0016710.3389/fchem.2019.00167 ↗
23. 10.1021/acsnano.5b0004210.1021/acsnano.5b00042 ↗
24. 10.1039/c0cs00018c10.1039/c0cs00018c ↗
25. 10.2147/nsa.s378810.2147/nsa.s3788 ↗
26. 10.1039/C7NR03828C10.1039/C7NR03828C ↗
27. 10.1016/j.actbio.2016.04.02410.1016/j.actbio.2016.04.024 ↗
28. 10.1021/acsami.7b1964010.1021/acsami.7b19640 ↗
29. 10.1039/d0tb00182a10.1039/d0tb00182a ↗
30. 10.1039/c8nr05558k10.1039/c8nr05558k ↗
31. 10.1016/j.materresbull.2018.11.01410.1016/j.materresbull.2018.11.014 ↗
32. 10.1016/j.jcis.2018.08.06910.1016/j.jcis.2018.08.069 ↗
33. 10.1007/s12274-015-0905-910.1007/s12274-015-0905-9 ↗
34. 10.1021/acsami.6b0572710.1021/acsami.6b05727 ↗
35. 10.1021/nn403202w10.1021/nn403202w ↗
36. 10.1021/acs.nanolett.8b0181810.1021/acs.nanolett.8b01818 ↗
37. 10.3892/mmr.2019.1021810.3892/mmr.2019.10218 ↗
38. 10.1021/acs.chemrev.6b0004810.1021/acs.chemrev.6b00048 ↗
39. 10.1039/c4ce00674g10.1039/c4ce00674g ↗
40. 10.1016/j.nantod.2020.10104610.1016/j.nantod.2020.101046 ↗
41. 10.1016/J.BIOMATERIALS.2011.05.00710.1016/J.BIOMATERIALS.2011.05.007 ↗
42. 10.1016/j.pdpdt.2017.04.00110.1016/j.pdpdt.2017.04.001 ↗
43. 10.1021/acs.chemmater.6b0219210.1021/acs.chemmater.6b02192 ↗
44. 10.1021/acsnano.7b0103210.1021/acsnano.7b01032 ↗
45. 10.3389/fbioe.2020.0002110.3389/fbioe.2020.00021 ↗
46. 10.1021/acsami.6b0994210.1021/acsami.6b09942 ↗
47. 10.1002/adfm.20200236210.1002/adfm.202002362 ↗
48. 10.1016/j.adcanc.2022.10004410.1016/j.adcanc.2022.100044 ↗
49. 10.7150/thno.1498810.7150/thno.14988 ↗
50. 10.1002/chem.20170419710.1002/chem.201704197 ↗
51. 10.1021/acs.biomac.8b0113810.1021/acs.biomac.8b01138 ↗
52. 10.1038/nmat377610.1038/nmat3776 ↗
53. 10.1039/C5NR08253F10.1039/C5NR08253F ↗
54. 10.1021/acsami.8b1506410.1021/acsami.8b15064 ↗
55. 10.1039/d0py00212g10.1039/d0py00212g ↗
56. 10.1021/mz300457e10.1021/mz300457e ↗
57. 10.1016/j.polymer.2019.01.02210.1016/j.polymer.2019.01.022 ↗
58. 10.1039/c7mh00016b10.1039/c7mh00016b ↗
59. 10.1007/s12551-016-0218-610.1007/s12551-016-0218-6 ↗
60. 10.1021/jp064341w10.1021/jp064341w ↗
61. 10.3762/bjnano.9.5910.3762/bjnano.9.59 ↗
62. 10.1016/j.biopha.2018.07.04910.1016/j.biopha.2018.07.049 ↗
63. 10.1016/j.biomaterials.2010.04.05510.1016/j.biomaterials.2010.04.055 ↗
64. 10.1021/nn506687t10.1021/nn506687t ↗
65. 10.1016/j.nano.2011.01.01410.1016/j.nano.2011.01.014 ↗
66. 10.1016/j.cej.2018.07.12410.1016/j.cej.2018.07.124 ↗
67. 10.1021/acsami.8b1622610.1021/acsami.8b16226 ↗
68. 10.1172/JCI7293110.1172/JCI72931 ↗
69. 10.1088/1361-6528/aa967b10.1088/1361-6528/aa967b ↗
70. 10.1021/mp100245u10.1021/mp100245u ↗
71. 10.1098/rsos.18056410.1098/rsos.180564 ↗
72. 10.1016/j.bbamcr.2016.12.00210.1016/j.bbamcr.2016.12.002 ↗
73. 10.1186/1745-6673-9-1110.1186/1745-6673-9-11 ↗
74. 10.1038/s41592-019-0581-x10.1038/s41592-019-0581-x ↗
75. 10.1109/TBME.2018.288214610.1109/TBME.2018.2882146 ↗